Alcyone Lifesciences and DNAtrix to Collaborate on Unique Delivery System to Treat Brain Tumors

March 21, 2013
Alcyone Lifesciences, a privately held biopharmaceutical medical device company focusing on developing products for the treatment of difficult neuropathological conditions, and DNAtrix, a privately held biotechnology company developing virus-based immunotherapy products for cancer, today announced a collaboration to investigate Alcyone's Microcatheter System for delivery of therapeutics for brain tumor.